ETF Managers Group, LLC Hookipa Pharma Inc. Transaction History

ETF Managers Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 23, 2023	SELL	$0.73 - $14.6 $1,825 - $36,514	-2,501 Reduced 15.49%	13,642 $11,000
Q3 2022 Nov 14, 2022	SELL	$1.27 - $15.0 $1,442 - $17,040	-1,136 Reduced 6.57%	16,143 $22,000
Q2 2022 Aug 15, 2022	BUY	$1.33 - $2.31 $10,895 - $18,923	8,192 Added 90.15%	17,279 $27,000
Q1 2022 May 13, 2022	BUY	$1.26 - $2.52 $41 - $83	33 Added 0.36%	9,087 $19,000
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.94 $4,336 - $11,054	-1,861 Reduced 17.05%	9,054 $22,000
Q3 2021 Nov 15, 2021	BUY	$5.89 - $9.35 $12,528 - $19,887	2,127 Added 24.2%	10,915 $66,000
Q2 2021 Aug 16, 2021	SELL	$9.16 - $19.51 $11,889 - $25,323	-1,298 Reduced 12.87%	8,788 $81,000
Q1 2021 May 17, 2021	SELL	$10.64 - $14.7 $25,536 - $35,280	-2,400 Reduced 19.22%	10,086 $135,000
Q4 2020 Feb 16, 2021	SELL	$9.32 - $13.63 $17,596 - $25,733	-1,888 Reduced 13.13%	12,486 $142,000
Q3 2020 Nov 16, 2020	BUY	$8.59 - $11.89 $60,980 - $84,407	7,099 Added 97.58%	14,374 $139,000
Q2 2020 Aug 14, 2020	BUY	$7.23 - $12.1 $52,598 - $88,027	7,275 New	7,275 $85,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.